This content is from: Premium
Life Sciences Funds Show Some Signs of Health
Many funds have erased a big slice of their early-year losses but still have a long way to go to break even.
Life sciences and biopharma hedge funds are on a three-month winning streak.A number of funds posted another round of strong gains in August, a month in which the broad market averages were down sharply. This has boosted hope that the devastating multiyear selloff among fledgling biopharma and other healthcare stocks
To continue reading, subscribe now to Premium Journalism. Already a subscriber? Login.